CPHI Worldwide: PCI to Share Expertise in Serialization and Safe Handling of Potent Molecules
pharmafile | September 26, 2016 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | CPhI
Leading pharmaceutical provider PCI Pharma Services will bring its expertise to the stage at CPHI Worldwide (Barcelona, October 4-6 2016) with two Speakers Corner slots at the ICSE Exhibitor Showcase.
On October 4 (13:30) David O’Connell, Director of Pharmaceutical Development, PCI Pharma Services, will present the first of the two topics – outlining the key elements for the safe handling and manufacture of solid dose potent molecules. The session will advise on the complexities of safe processing of highly potent products and key considerations when choosing an outsourcing partner including regulatory requirements.
Commenting on the theme of his presentation, David said: “The pharmaceutical landscape continues to evolve with R&D pipelines developing new chemical entities for a wide range of disease states. The market has seen a shift towards more specialist medicines such as oncological and neurological products, in turn leading to an increase in the number of potent compounds requiring expert management.
“With the complexities involved in the management of potent molecules and the regulatory requirements to ensure safe handling, it is imperative to use the right partner for successful development and manufacturing.”
The second speaker topic will be presented by Ian Parsonage, Senior Director of Global Serialization, PCI Pharma Services on October 5 (12:00) covering key considerations, lessons learned and best practices for global serialization strategy and implementation.
Ian commented: “With drug counterfeiting on the rise globally and regulatory deadlines fast approaching, the pharmaceutical supply chain will soon be at critical point to ensure patient safety. From drug manufacturers to distributors, supply chain partners need to make crucial decisions to upgrade production lines in compliance with traceability deadlines. I’m looking forward to sharing insights and best practices on how to execute a serialization strategy at the event.”
CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, hosts more than 36,000 visiting pharma professionals over three days. Over 2,500 exhibitors from over 150 countries gather at the event to attend more than 100 free industry seminars.
PCI will be exhibiting at CPhI on stand 3B16. To arrange a meeting, please contact sales@pciservices.com
To register for CPhI Worldwide, visit: http://www.cphi.com/europe/
Related Content
Pharmapack Predictions 2025: the Good the Bad and…. the Donald 2.0
Biologic approvals, drug delivery advancements, GLP-1 generics and the long-sought funding return to drive a …
Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance
13 December 2024 – Amsterdam, the Netherlands – CPHI Milan – the world’s largest pharma …
Stelis, Strides and Steriscience merge to form new CDMO
The CDMO launched earlier this year at the CPHI conference in Milan. The merger is …
